世界の慢性リンパ性白血病（CLL）治療市場予測（～2024年）

• 英文タイトル：Global Chronic Lymphocytic Leukemia (CLL) Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

• レポートコード：B-GIR09D3847
• 出版社/出版日：GlobalInfoResearch / 2019年9月18日
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、120ページ
• 納品方法：Eメール
• 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本調査レポートは、慢性リンパ性白血病（CLL）治療の世界市場について調べ、まとめました。種類別セグメントは、CLLの初期治療、CLLの二次治療等、用途別セグメントは、大人用、子供用等に区分しました。慢性リンパ性白血病（CLL）治療の世界市場概観、企業動向、企業別慢性リンパ性白血病（CLL）治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・慢性リンパ性白血病（CLL）治療の市場概観
・慢性リンパ性白血病（CLL）治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・慢性リンパ性白血病（CLL）治療の企業別販売動向、市場シェア、市場集中度、競争動向
・慢性リンパ性白血病（CLL）治療の世界市場規模
・慢性リンパ性白血病（CLL）治療の北米市場分析（アメリカ、カナダ、メキシコ等）
・慢性リンパ性白血病（CLL）治療のアメリカ市場規模推移
・慢性リンパ性白血病（CLL）治療のカナダ市場規模推移
・慢性リンパ性白血病（CLL）治療のメキシコ市場規模推移
・慢性リンパ性白血病（CLL）治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・慢性リンパ性白血病（CLL）治療のドイツ市場規模推移
・慢性リンパ性白血病（CLL）治療のイギリス市場規模推移
・慢性リンパ性白血病（CLL）治療のロシア市場規模推移
・慢性リンパ性白血病（CLL）治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・慢性リンパ性白血病（CLL）治療の日本市場規模推移
・慢性リンパ性白血病（CLL）治療の中国市場規模推移
・慢性リンパ性白血病（CLL）治療の韓国市場規模推移
・慢性リンパ性白血病（CLL）治療のインド市場規模推移
・慢性リンパ性白血病（CLL）治療の東南アジア市場規模推移
・慢性リンパ性白血病（CLL）治療の南米市場分析（ブラジル、アルゼンチン等）
・慢性リンパ性白血病（CLL）治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・慢性リンパ性白血病（CLL）治療の種類別分析/販売量、売上、市場シェア（CLLの初期治療、CLLの二次治療）
・慢性リンパ性白血病（CLL）治療の用途別分析/市場規模（大人用、子供用）
・慢性リンパ性白血病（CLL）治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・慢性リンパ性白血病（CLL）治療の販売チャネル・代理店・貿易業者・ディーラー分析

Treatment options for chronic lymphocytic leukemia (CLL) vary greatly, depending on the person’s age, the disease risk group, and the reason for treating (for example, which symptoms it is causing).

Scope of the Report:
The global Chronic Lymphocytic Leukemia (CLL) Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Chronic Lymphocytic Leukemia (CLL) Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Chronic Lymphocytic Leukemia (CLL) Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Chronic Lymphocytic Leukemia (CLL) Treatment market by product type and applications/end industries.

Market Segment by Companies, this report covers
Roche
AbbVie Company
Teva
Johnson & Johnson
Gilead Sciences
Novartis
ZIOPHARM Oncology
XEME Biopharma
TG Therapeutics
Regeneron
Ono Pharmaceutical

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Initial Treatment of CLL
Second-line Treatment of CLL

Market Segment by Applications, can be divided into
Adults
Children

レポート目次

Table of Contents

1 Chronic Lymphocytic Leukemia (CLL) Treatment Market Overview
1.1 Product Overview and Scope of Chronic Lymphocytic Leukemia (CLL) Treatment
1.2 Classification of Chronic Lymphocytic Leukemia (CLL) Treatment by Types
1.2.1 Global Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Comparison by Types (2019-2024)
1.2.2 Global Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Market Share by Types in 2018
1.2.3 Initial Treatment of CLL
1.2.4 Second-line Treatment of CLL
1.3 Global Chronic Lymphocytic Leukemia (CLL) Treatment Market by Application
1.3.1 Global Chronic Lymphocytic Leukemia (CLL) Treatment Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Adults
1.3.3 Children
1.4 Global Chronic Lymphocytic Leukemia (CLL) Treatment Market by Regions
1.4.1 Global Chronic Lymphocytic Leukemia (CLL) Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Chronic Lymphocytic Leukemia (CLL) Treatment Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Chronic Lymphocytic Leukemia (CLL) Treatment Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Chronic Lymphocytic Leukemia (CLL) Treatment Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Chronic Lymphocytic Leukemia (CLL) Treatment Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Chronic Lymphocytic Leukemia (CLL) Treatment Status and Prospect (2014-2024)
1.5 Global Market Size of Chronic Lymphocytic Leukemia (CLL) Treatment (2014-2024)
2 Manufacturers Profiles
2.1 Roche
2.1.1 Business Overview
2.1.2 Chronic Lymphocytic Leukemia (CLL) Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Roche Chronic Lymphocytic Leukemia (CLL) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.2 AbbVie Company
2.2.1 Business Overview
2.2.2 Chronic Lymphocytic Leukemia (CLL) Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 AbbVie Company Chronic Lymphocytic Leukemia (CLL) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.3 Teva
2.3.1 Business Overview
2.3.2 Chronic Lymphocytic Leukemia (CLL) Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Teva Chronic Lymphocytic Leukemia (CLL) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.4 Johnson & Johnson
2.4.1 Business Overview
2.4.2 Chronic Lymphocytic Leukemia (CLL) Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Johnson & Johnson Chronic Lymphocytic Leukemia (CLL) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.5 Gilead Sciences
2.5.1 Business Overview
2.5.2 Chronic Lymphocytic Leukemia (CLL) Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Gilead Sciences Chronic Lymphocytic Leukemia (CLL) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.6 Novartis
2.6.1 Business Overview
2.6.2 Chronic Lymphocytic Leukemia (CLL) Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Novartis Chronic Lymphocytic Leukemia (CLL) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.7 ZIOPHARM Oncology
2.7.1 Business Overview
2.7.2 Chronic Lymphocytic Leukemia (CLL) Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 ZIOPHARM Oncology Chronic Lymphocytic Leukemia (CLL) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.8 XEME Biopharma
2.8.1 Business Overview
2.8.2 Chronic Lymphocytic Leukemia (CLL) Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 XEME Biopharma Chronic Lymphocytic Leukemia (CLL) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.9 TG Therapeutics
2.9.1 Business Overview
2.9.2 Chronic Lymphocytic Leukemia (CLL) Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 TG Therapeutics Chronic Lymphocytic Leukemia (CLL) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.10 Regeneron
2.10.1 Business Overview
2.10.2 Chronic Lymphocytic Leukemia (CLL) Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Regeneron Chronic Lymphocytic Leukemia (CLL) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.11 Ono Pharmaceutical
2.11.1 Business Overview
2.11.2 Chronic Lymphocytic Leukemia (CLL) Treatment Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Ono Pharmaceutical Chronic Lymphocytic Leukemia (CLL) Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Chronic Lymphocytic Leukemia (CLL) Treatment Market Competition, by Players
3.1 Global Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Chronic Lymphocytic Leukemia (CLL) Treatment Players Market Share
3.2.2 Top 10 Chronic Lymphocytic Leukemia (CLL) Treatment Players Market Share
3.3 Market Competition Trend
4 Global Chronic Lymphocytic Leukemia (CLL) Treatment Market Size by Regions
4.1 Global Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Market Share by Regions
4.2 North America Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
4.3 Europe Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
4.5 South America Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
5 North America Chronic Lymphocytic Leukemia (CLL) Treatment Revenue by Countries
5.1 North America Chronic Lymphocytic Leukemia (CLL) Treatment Revenue by Countries (2014-2019)
5.2 USA Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
5.3 Canada Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
5.4 Mexico Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
6 Europe Chronic Lymphocytic Leukemia (CLL) Treatment Revenue by Countries
6.1 Europe Chronic Lymphocytic Leukemia (CLL) Treatment Revenue by Countries (2014-2019)
6.2 Germany Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
6.3 UK Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
6.4 France Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
6.5 Russia Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
6.6 Italy Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Chronic Lymphocytic Leukemia (CLL) Treatment Revenue by Countries
7.1 Asia-Pacific Chronic Lymphocytic Leukemia (CLL) Treatment Revenue by Countries (2014-2019)
7.2 China Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
7.3 Japan Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
7.4 Korea Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
7.5 India Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
8 South America Chronic Lymphocytic Leukemia (CLL) Treatment Revenue by Countries
8.1 South America Chronic Lymphocytic Leukemia (CLL) Treatment Revenue by Countries (2014-2019)
8.2 Brazil Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
8.3 Argentina Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
8.4 Colombia Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Chronic Lymphocytic Leukemia (CLL) Treatment by Countries
9.1 Middle East and Africa Chronic Lymphocytic Leukemia (CLL) Treatment Revenue by Countries (2014-2019)
9.2 Saudi Arabia Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
9.3 UAE Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
9.4 Egypt Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
9.5 Nigeria Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
9.6 South Africa Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
10 Global Chronic Lymphocytic Leukemia (CLL) Treatment Market Segment by Type
10.1 Global Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Market Share by Type (2014-2019)
10.2 Global Chronic Lymphocytic Leukemia (CLL) Treatment Market Forecast by Type (2019-2024)
10.3 Initial Treatment of CLL Revenue Growth Rate (2014-2024)
10.4 Second-line Treatment of CLL Revenue Growth Rate (2014-2024)
11 Global Chronic Lymphocytic Leukemia (CLL) Treatment Market Segment by Application
11.1 Global Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Market Share by Application (2014-2019)
11.2 Chronic Lymphocytic Leukemia (CLL) Treatment Market Forecast by Application (2019-2024)
11.3 Adults Revenue Growth (2014-2019)
11.4 Children Revenue Growth (2014-2019)
12 Global Chronic Lymphocytic Leukemia (CLL) Treatment Market Size Forecast (2019-2024)
12.1 Global Chronic Lymphocytic Leukemia (CLL) Treatment Market Size Forecast (2019-2024)
12.2 Global Chronic Lymphocytic Leukemia (CLL) Treatment Market Forecast by Regions (2019-2024)
12.3 North America Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Market Forecast (2019-2024)
12.4 Europe Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Market Forecast (2019-2024)
12.6 South America Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Chronic Lymphocytic Leukemia (CLL) Treatment Picture
Table Product Specifications of Chronic Lymphocytic Leukemia (CLL) Treatment
Table Global Chronic Lymphocytic Leukemia (CLL) Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Market Share by Types in 2018
Figure Initial Treatment of CLL Picture
Figure Second-line Treatment of CLL Picture
Table Global Chronic Lymphocytic Leukemia (CLL) Treatment Revenue (Million USD) by Application (2014-2024)
Figure Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Market Share by Applications in 2018
Figure Adults Picture
Figure Children Picture
Table Global Market Chronic Lymphocytic Leukemia (CLL) Treatment Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Chronic Lymphocytic Leukemia (CLL) Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Chronic Lymphocytic Leukemia (CLL) Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Chronic Lymphocytic Leukemia (CLL) Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Chronic Lymphocytic Leukemia (CLL) Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Chronic Lymphocytic Leukemia (CLL) Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Chronic Lymphocytic Leukemia (CLL) Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Chronic Lymphocytic Leukemia (CLL) Treatment Type and Applications
Table Roche Chronic Lymphocytic Leukemia (CLL) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table AbbVie Company Basic Information, Manufacturing Base and Competitors
Table AbbVie Company Chronic Lymphocytic Leukemia (CLL) Treatment Type and Applications
Table AbbVie Company Chronic Lymphocytic Leukemia (CLL) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Chronic Lymphocytic Leukemia (CLL) Treatment Type and Applications
Table Teva Chronic Lymphocytic Leukemia (CLL) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Chronic Lymphocytic Leukemia (CLL) Treatment Type and Applications
Table Johnson & Johnson Chronic Lymphocytic Leukemia (CLL) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table Gilead Sciences Chronic Lymphocytic Leukemia (CLL) Treatment Type and Applications
Table Gilead Sciences Chronic Lymphocytic Leukemia (CLL) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Chronic Lymphocytic Leukemia (CLL) Treatment Type and Applications
Table Novartis Chronic Lymphocytic Leukemia (CLL) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table ZIOPHARM Oncology Basic Information, Manufacturing Base and Competitors
Table ZIOPHARM Oncology Chronic Lymphocytic Leukemia (CLL) Treatment Type and Applications
Table ZIOPHARM Oncology Chronic Lymphocytic Leukemia (CLL) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table XEME Biopharma Basic Information, Manufacturing Base and Competitors
Table XEME Biopharma Chronic Lymphocytic Leukemia (CLL) Treatment Type and Applications
Table XEME Biopharma Chronic Lymphocytic Leukemia (CLL) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table TG Therapeutics Basic Information, Manufacturing Base and Competitors
Table TG Therapeutics Chronic Lymphocytic Leukemia (CLL) Treatment Type and Applications
Table TG Therapeutics Chronic Lymphocytic Leukemia (CLL) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Regeneron Basic Information, Manufacturing Base and Competitors
Table Regeneron Chronic Lymphocytic Leukemia (CLL) Treatment Type and Applications
Table Regeneron Chronic Lymphocytic Leukemia (CLL) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Ono Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Ono Pharmaceutical Chronic Lymphocytic Leukemia (CLL) Treatment Type and Applications
Table Ono Pharmaceutical Chronic Lymphocytic Leukemia (CLL) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Global Chronic Lymphocytic Leukemia (CLL) Treatment Revenue (Million USD) by Players (2014-2019)
Table Global Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Share by Players (2014-2019)
Figure Global Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Share by Players in 2017
Figure Global Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Share by Players in 2018
Figure Global Top 5 Players Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Market Share in 2018
Figure Global Top 10 Players Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Market Share in 2018
Figure Global Chronic Lymphocytic Leukemia (CLL) Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Chronic Lymphocytic Leukemia (CLL) Treatment Revenue (Million USD) by Regions (2014-2019)
Table Global Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Market Share by Regions in 2018
Figure North America Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
Figure Europe Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
Figure South America Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
Table North America Chronic Lymphocytic Leukemia (CLL) Treatment Revenue by Countries (2014-2019)
Table North America Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Market Share by Countries in 2018
Figure USA Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
Figure Canada Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
Figure Mexico Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
Table Europe Chronic Lymphocytic Leukemia (CLL) Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Europe Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Market Share by Countries in 2018
Figure Germany Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
Figure UK Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
Figure France Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
Figure Russia Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
Figure Italy Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Chronic Lymphocytic Leukemia (CLL) Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Market Share by Countries in 2018
Figure China Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
Figure Japan Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
Figure Korea Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
Figure India Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
Table South America Chronic Lymphocytic Leukemia (CLL) Treatment Revenue by Countries (2014-2019)
Table South America Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Market Share by Countries in 2018
Figure Brazil Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
Figure Argentina Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
Figure Colombia Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Chronic Lymphocytic Leukemia (CLL) Treatment Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
Figure UAE Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
Figure Egypt Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
Figure Nigeria Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
Figure South Africa Chronic Lymphocytic Leukemia (CLL) Treatment Revenue and Growth Rate (2014-2019)
Table Global Chronic Lymphocytic Leukemia (CLL) Treatment Revenue (Million USD) by Type (2014-2019)
Table Global Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Share by Type (2014-2019)
Figure Global Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Share by Type (2014-2019)
Figure Global Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Share by Type in 2019
Table Global Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Forecast by Type (2019-2024)
Figure Global Chronic Lymphocytic Leukemia (CLL) Treatment Market Share Forecast by Type (2019-2024)
Figure Global Initial Treatment of CLL Revenue Growth Rate (2014-2019)
Figure Global Second-line Treatment of CLL Revenue Growth Rate (2014-2019)
Table Global Chronic Lymphocytic Leukemia (CLL) Treatment Revenue by Application (2014-2019)
Table Global Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Share by Application (2014-2019)
Figure Global Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Share by Application (2014-2019)
Figure Global Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Share by Application in 2019
Table Global Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Forecast by Application (2019-2024)
Figure Global Chronic Lymphocytic Leukemia (CLL) Treatment Market Share Forecast by Application (2019-2024)
Figure Global Adults Revenue Growth Rate (2014-2019)
Figure Global Children Revenue Growth Rate (2014-2019)
Figure Global Chronic Lymphocytic Leukemia (CLL) Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Chronic Lymphocytic Leukemia (CLL) Treatment Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Market Forecast (2019-2024)
Figure Europe Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Market Forecast (2019-2024)
Figure South America Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Chronic Lymphocytic Leukemia (CLL) Treatment Revenue Market Forecast (2019-2024)

以下、関連資料のご紹介

世界の小児慢性副鼻腔炎治療市場予測（～2024年）

Global Pediatric Chronic Rhinosinusitis Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D4189 2019年9月18日 116Pages
本調査レポートは、小児慢性副鼻腔炎治療の世界市場について調べ、まとめました。種類別セグメントは、ステロイド、抗生物質、抗真菌療法、その他等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局等に区分しました。小児慢性副鼻腔炎治療の世界市場概観、企業動向、企業別小児慢性副鼻腔炎治療シェア、市場規模...

世界の良性前立腺過形成（BPH）治療市場予測（～2024年）

Global Benign Prostatic Hyperplasia (BPH) Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D3807 2019年9月18日 121Pages
本調査レポートは、良性前立腺過形成（BPH）治療の世界市場について調べ、まとめました。種類別セグメントは、薬、デバイス等、用途別セグメントは、病院、診療所、その他等に区分しました。良性前立腺過形成（BPH）治療の世界市場概観、企業動向、企業別良性前立腺過形成（BPH）治療シェア、市場規模推移、市場規...

世界の腎性全身性線維症（NSF）治療市場予測（～2024年）

Global Nephrogenic Systemic Fibrosis (NSF) Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D4156 2019年9月18日 115Pages
本調査レポートは、腎性全身性線維症（NSF）治療の世界市場について調べ、まとめました。種類別セグメントは、血液レオロジー剤、免疫調節薬、アルキル化剤、キナーゼ阻害剤、その他等、用途別セグメントは、病院、診療所、その他等に区分しました。腎性全身性線維症（NSF）治療の世界市場概観、企業動向、企業別腎性...

世界の物質使用障害（SUD）治療市場予測（～2024年）

Global Substance Use Disorders (SUDs) Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D4310 2019年9月18日 115Pages
本調査レポートは、物質使用障害（SUD）治療の世界市場について調べ、まとめました。種類別セグメントは、オピオイド中毒、タバコ/ニコチン中毒、アルコール依存症等、用途別セグメントは、病院及びクリニック、住宅（病院以外）等に区分しました。物質使用障害（SUD）治療の世界市場概観、企業動向、企業別物質使用...

世界の慢性気管支炎の治療市場予測（～2024年）

Global Chronic Bronchitis Treatment Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR09D0796 2019年9月4日 121Pages
本調査レポートは、慢性気管支炎の治療の世界市場について調べ、まとめました。種類別セグメントは、抗生物質、抗炎症薬、気管支拡張剤、粘液溶解薬等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局等に区分しました。慢性気管支炎の治療の世界市場概観、メーカー動向、メーカー別慢性気管支炎の治療シェア、市...

世界の腎疾患治療市場予測（～2024年）

Global Renal Disease Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D4259 2019年9月18日 118Pages
本調査レポートは、腎疾患治療の世界市場について調べ、まとめました。種類別セグメントは、急性腎障害、慢性腎疾患、その他等、用途別セグメントは、病院、診療所、研究センター、その他等に区分しました。腎疾患治療の世界市場概観、企業動向、企業別腎疾患治療シェア、市場規模推移、市場規模予測（2019年-2024...

白血病治療法市場：世界及び中国市場分析・予測（～2024年）

Leukemia Therapeutics Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
C9OT3813 2019年10月8日 147Pages
「白血病治療法市場：世界及び中国市場分析・予測（～2024年）」は、世界及び中国における白血病治療法市場について調査・分析したレポートで、白血病治療法の世界市場動向、市場規模、主要企業情報などが含まれています。白血病治療法のタイプ別には、グリベック、スプリセル、タシグナ、クロラー、その他に分けて分析...

白血病スクリーニング市場：世界及び中国市場分析・予測（～2024年）

Leukemia Screening Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
C9OT3812 2019年10月8日 139Pages
「白血病スクリーニング市場：世界及び中国市場分析・予測（～2024年）」は、世界及び中国における白血病スクリーニング市場について調査・分析したレポートで、白血病スクリーニングの世界市場動向、市場規模、主要企業情報などが含まれています。白血病スクリーニングのタイプ別には、骨髄吸引及び生検、胸部X線また...

世界の腱炎治療市場予測（～2024年）

Global Tendinitis Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D4320 2019年9月18日 124Pages
本調査レポートは、腱炎治療の世界市場について調べ、まとめました。種類別セグメントは、薬物療法、外科療法、その他等、用途別セグメントは、病院、診療所、その他等に区分しました。腱炎治療の世界市場概観、企業動向、企業別腱炎治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米...

急性骨髄性白血病治療市場：世界及び中国市場分析・予測（～2024年）

Acute Myeloid Leukemia Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
C9OT0141 2019年10月1日 149Pages
「急性骨髄性白血病治療市場：世界及び中国市場分析・予測（～2024年）」は、世界及び中国における急性骨髄性白血病治療市場について調査・分析したレポートで、急性骨髄性白血病治療の世界市場動向、市場規模、主要企業情報などが含まれています。急性骨髄性白血病治療のタイプ別には、化学療法、放射線療法、幹細胞移...

世界の小児慢性副鼻腔炎治療市場予測（～2024年） Pediatric chronic Rhinosinusitis is one of the major and common disorder among infants with significant morbidity. Its diagnosis involves sinus symptoms, with prolonged duration requiring standard medical therapy for more than 90 days. The main causative factors for pediatric chronic rhinosinusitis …
世界の慢性気管支炎の治療市場予測（～2024年） Bronchitis is a respiratory disease that causes inflammation in the airways, also known as bronchi, of the lungs. It leads to irritation and inflammation of the lining of bronchial tubes, which are responsible for carrying air to and from the lungs. Scope of the Report: The worldwide market for Chro…
世界の腎疾患治療市場予測（～2024年） Scope of the Report: The global Renal Disease Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, a…
白血病治療法市場：世界及び中国市場分析・予測（～2024年） Leukemia Therapeutics Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Leukemia Therapeutics industry with a focus on the Chinese market. The report provides key statistics on the market status of the Leukemia Therapeutics manu…
白血病スクリーニング市場：世界及び中国市場分析・予測（～2024年） Leukemia Screening Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Leukemia Screening industry with a focus on the Chinese market. The report provides key statistics on the market status of the Leukemia Screening manufacturers…